Tag - medicine-4

 
Menu
Search
 
July 28, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

MEDICINE 4

Japan Times
ASIA PACIFIC / Science & Health
Feb 19, 2022
These vaccines have been embraced by the world. Why not in China?
Two years into the pandemic, China's 1.4 billion people still don't have access to one of the most effective coronavirus vaccines the world has to offer.
Japan Times
COMMENTARY / Japan
Feb 18, 2022
Investments in health systems will protect human security now, and into the future
COVID-19 has exposed the deep inequities and weaknesses in the global health system.
Japan Times
JAPAN
Feb 16, 2022
Women overtake men for first time in exam pass rate at Japan's medical schools
The average exam pass rate for women at the country's 81 universities with a medical faculty stood at 13.60% against men's 13.51%.
Japan Times
WORLD
Feb 14, 2022
Here’s what the pandemic has in store for the world next
As a virus-weary world limps through the third year of the outbreak, experts warn that omicron won't be the last variant we have to contend with.
Japan Times
COMMENTARY / World
Feb 11, 2022
Breaking the coronavirus pandemic's grip
There is a significant risk that we will become trapped in an endless cycle of booster vaccinations, chasing the virus rather than getting ahead of it.
Japan Times
JAPAN / Science & Health
Feb 10, 2022
Japanese health ministry approves Pfizer's COVID-19 oral treatment drug
The drug, paxlovid, is to be used for the treatment of mild-to-moderate COVID-19 in people 12 and older and who are at high risk of developing severe symptoms.
Japan Times
JAPAN
Feb 8, 2022
Japan to consider early approval for Shionogi COVID-19 pill
The company could file for early approval of the drug as soon as next week, and it could deliver enough doses for 1 million people by the end of March.
Japan Times
WORLD
Feb 4, 2022
COVID’s endemic shift means a slowdown for virus product makers
Demand for at-home tests will probably slow first while sales of more reliable PCRs will show more resilience, according to medical supply executives.
Japan Times
WORLD / Science & Health
Feb 1, 2022
How does Merck's COVID-19 pill compare to Pfizer's?
Pfizer said final trial results showed that its treatment reduced the chance of hospitalization or death by 89%, while Merck said their pill reduced those chances by 30%.
Japan Times
JAPAN / Science & Health
Jan 27, 2022
Some antibody drugs for COVID-19 may not be effective on omicron
Some antibody medicines, including Ronapreve, may not be effective against the highly mutated omicron variant of the coronavirus, according to researchers at Japanese and U.S. institutes.
Japan Times
WORLD / Science & Health
Jan 24, 2022
Rich countries lure health workers from low-income nations to fight shortages
The urgency and strong pull from high-income nations has raised new questions about the ethics of recruitment from countries with weak health systems during a pandemic.
Japan Times
ASIA PACIFIC / Science & Health
Jan 16, 2022
Beijing tightens rules for entering city after omicron case
On Saturday, the Beijing reported the first local infection of the omicron variant involving a person who had visited multiple malls and restaurants in the previous days.
Japan Times
WORLD / Science & Health
Jan 16, 2022
The decades of discoveries before the ‘miraculous’ sprint to a vaccine
The breakthroughs behind the vaccines unfolded over decades, little by little, as scientists across the world pursued research in disparate areas.
Japan Times
COMMENTARY / World
Jan 14, 2022
The great COVID-19 coverup
COVID-19 deaths make all the headlines, but what flies under the radar are the increased rates of obesity, unemployment, depression, alcoholism and suicides.
Japan Times
COMMENTARY / Japan
Jan 12, 2022
SOFA exempts U.S. forces from Japan’s laws, as it does its COVID safety measures
Beyond the issues associated with the U.S. military's lax COVID-19 containment measures, SOFA has a long history of incidents.
Japan Times
WORLD / Science & Health
Jan 12, 2022
Biogen stung as U.S. limits coverage of Alzheimer’s therapy
Private insurers in the U.S. have mostly declined to cover Aduhelm, saying they need more proof of its efficacy and that benefits outweigh risks like brain swelling.
Japan Times
WORLD / Science & Health
Jan 11, 2022
Pfizer starts making vaccine that targets both omicron and the original COVID virus
While research continues, Pfizer will evaluate the new hybrid shot against one specific to omicron and determine which should move forward by March, the firm's CEO has said.
Japan Times
COMMENTARY / World
Jan 10, 2022
Unvaccinated creating another kind of COVID-19 victim
People who make choices that are likely to harm others, such as refusing vaccinations, and have been warned of the consequences of those choices must take responsibility for them.
Japan Times
ASIA PACIFIC / Politics
Jan 6, 2022
Hair-loss treatment for votes? South Korea's hairy debate
The Democratic Party presidential candidate has divided opinion with his proposal to allow public health care insurance to cover hair-loss treatment.
Japan Times
COMMENTARY / World
Jan 5, 2022
Boris Johnson and the woeful and costly Tory war on woke
While freedom-loving Tories make their last stand, the evidence shows that coordinated action by governments and solidarity among citizens are what will contain the pandemic.
Japan's population continues to fall even as foreign resident count rises
The number of residents in Tokyo as of Jan. 1 rose by 0.03% from a year before, data shows, marking a year-on-year increase for the first time in three years, while the country's other 46 prefectures saw their populations continue to decline.
Ahead of the Olympics, Japan is still talking about the gymnast who won't be there
Japan's Shoko Miyata withdrew from the gymnastics team herself over her drinking and smoking, although it had already appeared as though the association was prepared to send her home from the team’s training camp in Monaco.
Yen melt-up nudges Japanese stocks into correction territory
Japanese stocks are down 10% from their July peak as the yen strengthens.
‘Crazy’ yen rally is at risk of shattering as soon as Wednesday
Some investors are warning that a yen rally is fragile, as was on show this week when the yen rapidly retraced an advance after Thursday’s stronger-than-expected U.S. economic growth figures.
Japan's average life expectancy rises for first time in three years
A decline in COVID-19-caused deaths likely helped boost the average life expectancy for Japanese men and women to rise for the first time in three years in 2023.
The Japanese Olympians looking to shine in Paris
Rim Nakamura, who is attempting to win Japan's first Olympic gold medal in cycling, will be one of the top Japanese athletes to watch at the Paris Games.
Japan’s minimum wage set for record ¥50 hike in major boost
Demonstrators rally to demand a big hike in minimum wages in Tokyo last week.
Japan loses top spot on strongest passport list to Singapore
Japan had the strongest passport for six years running from 2018, before being dethroned by Singapore on the 2024 list.
Why Japan's mysterious stash of classified funds escapes scrutiny
Prime Minister Fumio Kishida and Chief Cabinet Secretary Yoshimasa Hayashi (right) during a meeting in Tokyo on Tuesday.
Japan eyes gold — and the future — as Olympic men's soccer campaign begins
Japan midfielder Yu Hirakawa controls the ball during a match against the United States in Kansas City, Kansas, on June 11.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Traditional folk rituals like Mizudome-no-mai (dance to stop the rain) provide a sense of agency to a population that feels largely powerless in the face of the climate crisis.
As climate extremes intensify, Japan embraces ancient weather rituals
By Alex K.T. Martin

SUSTAINABLE JAPAN

JNTO promotes sustainable tourism initiatives
JNTO promotes sustainable tourism initiatives

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER